Pamela Morris to Follow-Up Studies
This is a "connection" page, showing publications Pamela Morris has written about Follow-Up Studies.
Connection Strength
0.027
-
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574.
Score: 0.022
-
Gender differences in left ventricular functional response to aortic valve replacement. Circulation. 1994 Nov; 90(5 Pt 2):II183-9.
Score: 0.005